Wilms Tumor 1 gene expression levels improve risk stratification in AML patients. Results of a multicentre study within the Spanish Group for Molecular Biology in Haematology

Br J Haematol. 2018 May;181(4):542-546. doi: 10.1111/bjh.14635. Epub 2017 Apr 3.
No abstract available

Keywords: Wilms Tumor 1; acute myeloid leukaemia; chemotherapy; minimal residual disease; stem cell transplantation.

Publication types

  • Letter
  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Female
  • Gene Expression Regulation, Leukemic*
  • Humans
  • Leukemia, Myeloid, Acute / drug therapy
  • Leukemia, Myeloid, Acute / genetics
  • Leukemia, Myeloid, Acute / metabolism*
  • Leukemia, Myeloid, Acute / mortality*
  • Male
  • Middle Aged
  • Neoplasm, Residual
  • Risk Assessment
  • Risk Factors
  • Spain / epidemiology
  • WT1 Proteins / biosynthesis*
  • WT1 Proteins / genetics

Substances

  • WT1 Proteins
  • WT1 protein, human